Douglass H. Laidlaw
Plus aucun poste en cours
Profil
Douglass H.
Laidlaw worked as a Director-Medical Affairs at Keryx Biopharmaceuticals, Inc. and as a Senior Director-Medical Affairs at Talaris Therapeutics, Inc. He also worked as a Vice President-Medical Affairs at OPKO Health, Inc. from 2016 to 2017.
Laidlaw completed his undergraduate degree at Sonoma State University and his graduate and doctorate degrees at the University of Arizona.
Anciens postes connus de Douglass H. Laidlaw
| Sociétés | Poste | Fin |
|---|---|---|
| TOURMALINE BIO, INC. | Directeur Technique/Scientifique/R&D | 01/02/2023 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01/06/2017 |
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | - |
Formation de Douglass H. Laidlaw
| University of Arizona | Doctorate Degree |
| Sonoma State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OPKO HEALTH, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
